GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Acadia Healthcare Co Inc (NAS:ACHC) » Definitions » Altman Z2-Score

Acadia Healthcare Co (Acadia Healthcare Co) Altman Z2-Score : 0.98 (As of Apr. 27, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Acadia Healthcare Co Altman Z2-Score?

Altman Z2-Score, also known as Z"-Score, is used to predict the likelihood that a non-manufacturing company (excluding property/financial company) will face bankruptcy within a two-year period.

Warning Sign:

Acadia Healthcare Co has a Altman Z2-Score of 0.98, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.

The zones of discrimination were as such:

When Altman Z2-Score <= 1.1, it is in Distress Zones.
When Altman Z2-Score >= 2.6, it is in Safe Zones.
When Altman Z2-Score is between 1.1 and 2.6, it is in Grey Zones.

The historical rank and industry rank for Acadia Healthcare Co's Altman Z2-Score or its related term are showing as below:

ACHC' s Altman Z2-Score Range Over the Past 10 Years
Min: 0.98   Med: 1.37   Max: 2.27
Current: 0.98

During the past 13 years, Acadia Healthcare Co's highest Altman Z2-Score was 2.27. The lowest was 0.98. And the median was 1.37.


Acadia Healthcare Co Altman Z2-Score Historical Data

The historical data trend for Acadia Healthcare Co's Altman Z2-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acadia Healthcare Co Altman Z2-Score Chart

Acadia Healthcare Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Altman Z2-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.11 1.86 1.75 2.27 0.98

Acadia Healthcare Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Altman Z2-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.27 2.37 2.39 1.05 0.98

Competitive Comparison of Acadia Healthcare Co's Altman Z2-Score

For the Medical Care Facilities subindustry, Acadia Healthcare Co's Altman Z2-Score, along with its competitors' market caps and Altman Z2-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Acadia Healthcare Co's Altman Z2-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Acadia Healthcare Co's Altman Z2-Score distribution charts can be found below:

* The bar in red indicates where Acadia Healthcare Co's Altman Z2-Score falls into.



Acadia Healthcare Co Altman Z2-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Z2-Score, also known as Z"-Score is the Z-Score for non-manufacturing companies excluding property/financial companies.

Acadia Healthcare Co's Altman Z2-Score for today is calculated with this formula:

Z=6.56*X1+3.26*X2+6.72*X3+1.05*X4_2
=6.56*-0.0541+3.26*0.0246+6.72*0.0106+1.05*1.1258
=0.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z2-Score when X4_2 value is 0.

Trailing Twelve Months (TTM) ended in Dec. 2023:
Total Assets was $5,359 Mil.
Total Current Assets was $596 Mil.
Total Current Liabilities was $886 Mil.
Retained Earnings was $132 Mil.
Pre-Tax Income was 79.965 + -287.398 + 96.43 + 85.643 = $-25 Mil.
Interest Expense was -20.474 + -20.742 + -20.91 + -19.999 = $-82 Mil.
Total Liabilities was $2,471 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(596 - 885.781)/5358.841
=-0.0541

X2=Retained Earnings/Total Assets
=131.721/5358.841
=0.0246

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(-25.36 - -82.125)/5358.841
=0.0106

X4_2=Net Worth/Total Liabilities
=(Total Stockholders Equity - Preferred Stock)/Total Liabilities
=(2781.974 - 0)/2471.181
=1.1258

The zones of discrimination were as such:

Distress Zones - 1.1 < Grey Zones < 2.6 - Safe Zones

Acadia Healthcare Co has a Altman Z2-Score of 0.98 indicating it is in Distress Zones.


Acadia Healthcare Co  (NAS:ACHC) Altman Z2-Score Explanation

The original Z-Score model was based on publicly traded manufacturing companies while the Z2-Score, also known as Z"-score can be used for any type of company excluding property/financial companies. Both Z-Score and Z2-Score describes the financial health of a company, and its likelihood of financial distress.

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4_2, Net Worth (Total Stockholders Equity - Preferred Stock)/Total Liabilities (NW/TL): it compares a company’s stock net worth with its total liabilities and can be used to assess the extent of its reliance on debt.

Read more about Altman Z2-Score, the original research on Z-Score and the additional research on Z2-Score.


Be Aware

Altman Z2-Score does not apply to financial companies.


Acadia Healthcare Co Altman Z2-Score Related Terms

Thank you for viewing the detailed overview of Acadia Healthcare Co's Altman Z2-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Acadia Healthcare Co (Acadia Healthcare Co) Business Description

Traded in Other Exchanges
Address
6100 Tower Circle, Suite 1000, Franklin, TN, USA, 37067
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities in the United States, United Kingdom, and Puerto Rico. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The U.S. facilities receive the largest proportion of payments from Medicaid, with the second-largest proportion from commercial payors. In the United Kingdom, the majority of Acadia's revenue comes from its healthcare facilities, and virtually all of the payment received is from the National Health Service.
Executives
Debra K Osteen director, officer: Chief Executive Officer 367 SOUTH GULPH ROAD, KING PRUSSIA PA 19406
John S. Hollinsworth officer: EVP of Operations 6100 TOWER CIRCLE, SUITE 1000, FRANKLIN TN 37067
Patrice A Harris director 514 MARKET ST., PARKERSBURG WV 26101
Brian Farley officer: EVP , GC and Secretary 222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO IL 60654
Heather Brianne Dixon officer: Chief Financial Officer AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156
William Grieco director 830 CRESCENT CENTRE DRIVE, SUITE 610, FRANKLIN TN 37067
William M Petrie director 310 25TH AVENUE NORTH, SUITE 309, NASHVILLE TN 37203
Ralph David Kelly director 4005 WOOD LAKE DRIVE, PLANO TX 75093
Christopher H. Hunter director, officer: Chief Executive Officer 500 W MAIN STREET, LOUISVILLE KY 40202
Reeve B Waud director, 10 percent owner 300 N LASALLE ST, SUITE 4900, CHICAGO IL 60654
David M. Duckworth officer: Chief Financial Officer 830 CRESCENT CENTRE DRIVE, SUITE 610, FRANKLIN TN 37067
Christopher L Howard 10 percent owner, officer: EVP, GC and Secretary 830 CRESCENT CENTRE DRIVE, SUITE 610, FRANKLIN TN 37067
Michael Fucci director 6100 TOWER CIR #1000, FRANKLIN TN 37067
Jason Bernhard director 6100 TOWER CIRCLE, SUITE 1000, FRANKLIN TN 37067
Laurence L. Harrod officer: EVP of Finance 6100 TOWER CIRCLE, SUITE 1000, FRANKLIN TN 37067